Subtype
Cervical Neoplasm
CI-CAN-00004801Explore in graph →
Non-malignant573 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004801Explore in graph →
Clinical trials
2,386 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03808857 | A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive | unknown | Phase 2 | 80 | Genor Biopharma Co., Ltd.INDUSTRY | 1 | Mar 3, 2021 | clinicaltrials |
| NCT04664244 | Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma | unknown | Phase 2 | 43 | Lei LiOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT04650711 |
| Immunohistochemical Staining of p16 for the Screening of Cervical Cancer |
| unknown |
| Phase 2 |
| 250 |
| Lei LiOTHER |
| 1 |
| Dec 3, 2020 |
| clinicaltrials |
| NCT04635956 | Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas | unknown | Phase 2 | 20 | Lei LiOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT03295526 | Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer | unknown | Phase 2 | 200 | Fudan UniversityOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT04368273 | Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer.(CCRT+PD-1) | unknown | Phase 1 / Phase 2 | 30 | Peking University Third HospitalOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT04310774 | CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer | unknown | Phase 1 / Phase 2 | 200 | Peking Union Medical College HospitalOTHER | 0 | Mar 19, 2020 | clinicaltrials |
| NCT03274206 | A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3) | unknown | Phase 2 | 126 | BioLeaders CorporationINDUSTRY | 1 | Feb 7, 2020 | clinicaltrials |
| NCT04121975 | CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer | unknown | Phase 2 | 82 | Zhejiang Cancer HospitalOTHER | 1 | Oct 10, 2019 | clinicaltrials |
| NCT04096911 | Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer | unknown | Phase 2 | 20 | Buhai WangOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT03550755 | Immunotherapy of Cervical Cancer With V3-Cervix(V3-Cervix) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03963882 | NAC Followed by RH for the Treatment of LACC | unknown | Phase 2 | 60 | Lei LiOTHER | 1 | Jun 20, 2019 | clinicaltrials |
| NCT03972722 | Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer(CC) | unknown | Phase 2 | 89 | Guangzhou Gloria Biosciences Co., Ltd.INDUSTRY | 1 | Jun 5, 2019 | clinicaltrials |
| NCT02349958 | Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy(HIPEC/IPHC) | unknown | Phase 2 | 200 | Bay Area Gynecology OncologyOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03745846 | A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization | unknown | Phase 2 | 78 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Nov 19, 2018 | clinicaltrials |
| NCT01037049 | Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks | unknown | Phase 2 | 237 | Royal Marsden NHS Foundation TrustOTHER | 4 | Sep 17, 2018 | clinicaltrials |
| NCT03622827 | Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer(ChESS) | unknown | Phase 2 | 120 | Nanjing Medical UniversityOTHER | 1 | Aug 14, 2018 | clinicaltrials |
| NCT03469531 | Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 100 | Zhujiang HospitalOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT03546855 | Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy. | unknown | Phase 2 | 69 | Anhui Provincial HospitalOTHER_GOV | 0 | Jun 6, 2018 | clinicaltrials |
| NCT02879214 | Simultaneously Integrated Dose Escalation for Locally Advanced Cervical Cancer(Side) | unknown | Phase 2 | 50 | Sichuan Provincial People's HospitalOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT02432365 | Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy | unknown | Phase 2 | 64 | Chang Gung Memorial HospitalOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT02596243 | Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E) | unknown | Phase 2 | 134 | Genexine, Inc.INDUSTRY | 3 | Jul 12, 2017 | clinicaltrials |
| NCT03163979 | Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer(PROGRAMMA) | unknown | Phase 2 / Phase 3 | 300 | Nanjing Medical UniversityOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT02835404 | Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer | unknown | Phase 2 | 200 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jul 18, 2016 | clinicaltrials |
| NCT02705612 | Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer | unknown | Phase 2 | 60 | Air Force Military Medical University, ChinaOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT02039791 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer | unknown | Phase 2 | 20 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT02482740 | A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix(TGOG1005) | unknown | Phase 2 | 44 | Buddhist Tzu Chi General HospitalOTHER | 1 | Jun 26, 2015 | clinicaltrials |
| NCT02406365 | Diagnostic Imaging Aid for Management of Cervical Lesions(FFC) | unknown | Phase 2 | 618 | Brookdale University Hospital Medical CenterOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT01999933 | Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer | unknown | Phase 2 / Phase 3 | 600 | Mei ShiOTHER | 1 | Dec 3, 2013 | clinicaltrials |
| NCT01938105 | Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer | unknown | Phase 2 | 40 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Sep 26, 2013 | clinicaltrials |
| NCT00462397 | Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | unknown | Phase 2 | 50 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00632047 | Early Detection of Breast Cancer and Cervical Cancer in Women in India | unknown | Phase 2 | 151,538 | Tata Memorial HospitalOTHER_GOV | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00008112 | Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer | unknown | Phase 2 | — | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01594099 | Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women | unknown | Phase 2 | 45 | Xi'an Jiaotong UniversityOTHER | 0 | May 8, 2012 | clinicaltrials |
| NCT01487226 | Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer | unknown | Phase 2 | 69 | Korean Gynecologic Oncology GroupOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT01095198 | Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) | unknown | Phase 2 / Phase 3 | 1,440 | McMaster UniversityOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT00292955 | Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma | unknown | Phase 2 | 30 | University of VirginiaOTHER | 1 | May 30, 2011 | clinicaltrials |
| NCT01158248 | Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer | unknown | Phase 2 | 50 | Medical University InnsbruckOTHER | 1 | Jul 9, 2010 | clinicaltrials |
| NCT00178802 | Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers | unknown | Phase 2 | 24 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 23, 2010 | clinicaltrials |
| NCT00905658 | Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer | unknown | Phase 2 | 120 | Centre Oscar LambretOTHER | 1 | Jul 29, 2009 | clinicaltrials |
| NCT00003135 | Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer | unknown | Phase 2 | 34 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 30, 2009 | clinicaltrials |
| NCT00826891 | Study of Cisplatin in Cervical Cancer Stage IVB | unknown | Phase 2 | 40 | Chinese Anti-Cancer AssociationOTHER | 0 | Jan 22, 2009 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00199680 | Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer | unknown | Phase 2 | 42 | University Hospital, LimogesOTHER | 1 | Feb 1, 2006 | clinicaltrials |
| NCT00039884 | Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia? | unknown | Phase 2 | 64 | Mirhashemi, Ramin, M.D.INDIV | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Mar 3, 2021source: clinicaltrials